Home/Pipeline/RN0191

RN0191

Cardiovascular Disease (PCSK9)

Phase 1Active

Key Facts

Indication
Cardiovascular Disease (PCSK9)
Phase
Phase 1
Status
Active
Company

About Rona Therapeutics

A clinical-stage biotech developing long-acting siRNA therapeutics for metabolic and degenerative diseases using proprietary liver and extrahepatic delivery platforms.

View full company profile